Alex Azar: Pharma Lobbyist for Medical Record-Stealing GlaxoSmithKline
Prior to his appointment, HHS Secretary Alex Azar was an executive of the pharmaceutical company Eli Lilly. Even worse, he was on the board of directors of the Biotechnology Innovation Organization (BIO). BIO is a pharmaceutical lobbying group whose members include GlaxoSmithKline. GSK stole medical records of children in the seminal autism-vaccine research to defame its lead researcher and engineered the Homeland Security rider to shield the mercury-based vaccine preservative thimerosal from vaccine litigation. Azar has defamed the seminal autism-vaccine research even after its lead scientist met with Donald Trump.
During the election, GlaxoSmithKline did not want President Trump to win. The company even announced just before the 2016 election that it would appoint Emma Walmsley its new She-E-O, breaking the pharmaceutical glass ceiling before Hillary was expected to break the presidential one. It didn’t happen for Hillary.
At the time of Azar’s nomination, the head of FDA was unapologetic GlaxoSmithKline advisor Scott Gottlieb. During the transition, Trump’s personal lawyer Michael Cohen shared a vaccine troll’s blog post favoring Gottlieb’s FDA candidacy with the CEO of Novartis. Gottlieb would later announce his resignation from FDA the week after Cohen gave congressional testimony about his relationship with President Trump and Novartis. The month after Gottlieb’s departure, Cohen began his three-year prison sentence.
But Alex Azar remains HHS secretary. He is leading an “all hands on deck” approach to pushing toxic vaccinations on America’s children with President Trump’s blessing.
As @SecAzar told the National Vaccine Advisory Committee this past week, vaccines are safe, tested, and one of our greatest public health tools. Learn more about the importance of vaccines at https://t.co/wcXk7L8le7. pic.twitter.com/y8Co4zKg5X
— HHS.gov (@HHSGov) June 10, 2019
The post Alex Azar: Pharma Lobbyist for Medical Record-Stealing GlaxoSmithKline appeared first on Autism Investigated.